Response to treatment of cutaneous leishmaniasis with intralesional chloroquine vs intralesional meglumine antimoniate

Journal of Pakistan Association of Dermatologists

Volumn 21, Issue 4, 2011, Pages 270-275

  Yasmin, Rifat ^a   Khan, Ikramullah ^a   Ahmad, Syed Afaq ^a  

^a PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

Chloroquine; Cutaneous leishmaniasis; Intralesional; Meglumine antimoniate

Indexed keywords

ANTIBIOTIC AGENT; CHLOROQUINE; MEGLUMINE ANTIMONATE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; QUASI EXPERIMENTAL STUDY; SCAR FORMATION; SECONDARY INFECTION; SKIN LEISHMANIASIS; TREATMENT RESPONSE;

EID: 84859344338     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vega-Lopez F, Hay RJ. Leishmaniasis. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. London: Blackwell Science; 2004. p. 32:32-35-47.
2. Magill AJ. Leishmaniasis. In: Hunter GW, Strickland GT, eds. Hunter's Tropical Medicine and Emerging Infectious Diseases. 8th ed. Philadelphia: WB Saunders; 2000. P. 665-87.
3. Dedet JP, Pratlong F. Leishmaniasis. In: Manson P, Cook GC, Zumla A, eds. Manson's Tropical Disease. 21st edn. London: WB Saunders; 2003. p. 1339-64.
4. World Health Organization (WHO): Weekly epidemiological record No. 44. Vol 77. 2002; 365-372.
5. Bhutto AM, Soomro RA, Nonaka S, Hashiguchi Y. Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6-year study. Int J Dermatol 2003; 42: 543-8.
6. Ayub S, Gramiccia M, Khalid M et al. Cutaneous leishmaniasis in Multan: species identification. J Pak Med Assoc 2003; 53: 445-7.
7. Jaffernay M, Nighat R. Cutaneous leishmaniasis in Pakistan. Int J Dermatol 2001; 40: 159.
8. Kolaczinski J, Brooker S, Reyburn H, Rowland M. Epidemiology of anthroponotic cutaneous leishmaniasis in Afghan refugee camps in northwest Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 373-8.
9. Rahman S, Bari A. Laboratory profile in patients of cutaneous leishmaniasis from various regions of Pakistan. J Coll Physicians Surg Pak 2003; 13: 313-6.
10. Rogers ME, Ilg T, Nikolaev AV et al. Transmission of cutaneous leishmaniasis by sandflies is enhanced by regurgitation of fPPG. Nature 2004; 430: 463-7.
11. Iftikhar N, Bari I, Ejaz A. Rare variants of cutaneous leishmaniasis: whitlow, paronychia, and sporotrichoid. Int J Dermatol 2003; 42: 807-9.
12. Paredes R, Munoz J, Diaz I et al. Leishmaniasis in HIV infection. J Postgrad Med 2003;49:39-49.
13. Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment 2005, 44th edn. New York: McGraw-Hill; 2004.
14. Faber WR, Oskam L, van Gool T et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003; 49: 70-4.
15. Esfandiarpour, Alavi A. Evaluating the efficacy of allopurinol and meglumine antimonite (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol 2002; 41: 521-4.
16. ZvulunovA, Klaus S, Vardy D et al. Fluconazole for the treatment of cutaneous leishmaniasis. N Engl J Med 2002; 347: 370-1.
17. Alrajhi AA, Ibrahim EA, Devol EB et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891-5.
18. Soto J, Toledo J, Gutierrez P et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001; 33: e57-61.
19. Sundar S, Jha TK, Thakur CP et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347: 1739-46.
20. Lee SA, Hasbun R. Therapy of cutaneous leishmaniasis. Int J Infect Dis 2003; 7: 86-93.
21. Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. BMJ 2003; 326: 377-82.
22. Gurei MS, Tatli N, Ozbilge H et al. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000; 30: 169-76.
23. Noor SM, Hussain D. Intralesional chloroquine in cutaneous leishmaniasis. J Pak Assoc Dermatol 2005; 15: 18-21.
24. Arevalo I, Ward B, Miller R et al. Successful treatment of drug resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 2001; 33: 1847-51.
25. KroegerA, Avila EV, Morison L. Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: Cluster randomized trial. BMJ 2002; 325: 810-3.